ArticleBMC psychiatry2025
The interplay between homocysteine, oxidative stress, and butyrylcholinesterase activity in the pathogenesis of schizophrenia.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchizophrenia (SCZ) is a serious mental illness linked to neurobiological problems, such as hyperhomocysteinemia (HHC), increased butyrylcholinesterase (BChE) activity, and a pro-oxidant status. However, it remains unclear how these different markers interact with each other. This study aimed to analyze oxidative status, Hcys, and BChE activity variations in male drug-free SCZ patients compared to healthy controls.
methodsWe conducted a case-control study on male drug-free patients with SCZ. Metabolic parameters, oxidative status, Hcys, BChE activity, and ultrasensitive C-reactive protein (CRP) were tested for both groups.
resultsCRP and BChE levels were significantly higher in SCZ. A significant positive correlation was identified between BChE activity and PANSS Positive and General scores. Patients had lower levels of folate and vitamin B12 and concurrently higher levels of Hcys compared to controls. A significant positive correlation was found between Hcys levels and the PANSS Positive (r = 0.423, p < 0.001) and Negative scores (r = 0.414, p < 0.001). The correlation matrix shows strong associations between Hcys and oxidative markers, namely, reduced glutathione (GSH) and malondialdehyde (MDA) levels. Using a binary logistic regression model, the occurrence of psychotic decompensation was independently associated with BChE, GSH, and MDA.
conclusionThis study offers valuable insights into the intricate cholinergic, oxidative, and inflammatory processes linked to SCZ, which further exacerbate the clinical symptoms into a vicious cycle. Elevated Hcys levels appear mainly as a consequence of folate and vitamin B12 deficiencies rather than a direct pathogenic factor, underlining the need for integrated biomarker-based and nutritional approaches to improve patient outcomes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.